within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A05B_LiverTherapyLipotropics.A05BA08_GlycyrrhizicAcid;

model GlycyrrhizicAcid
  extends Pharmacolibrary.Drugs.ATC.A.A05BA08;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A05BA08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Glycyrrhizic acid is the principal active constituent of licorice root (Glycyrrhiza glabra) and is known for its anti-inflammatory, hepatoprotective, and antiviral properties. It has been used in the treatment of chronic hepatitis and as a component in traditional medicine. It is not a first-line or widely approved drug in modern Western medicine but may still be used in certain countries as an adjunct in liver disorders.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic values estimated from available literature reviews and studies with healthy adult volunteers, oral administration.</p><h4>References</h4><ol><li><p>Shen, C, et al., &amp; Li, X (2021). Glycyrrhizic acid-based self-assembled micelles for improving oral bioavailability of paeoniflorin. <i>Drug development and industrial pharmacy</i> 47(2) 207–214. DOI:<a href=\"https://doi.org/10.1080/03639045.2020.1862178\">10.1080/03639045.2020.1862178</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33305640/\">https://pubmed.ncbi.nlm.nih.gov/33305640</a></p></li><li><p>Xu, B, et al., &amp; Zhang, G (2015). Comparative pharmacokinetics of puerarin, daidzin, baicalin, glycyrrhizic acid, liquiritin, berberine, palmatine and jateorhizine by liquid chromatography-mass spectrometry after oral administration of Gegenqinlian decoction and active components alignment (ACA) to rats. <i>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</i> 988 33–44. DOI:<a href=\"https://doi.org/10.1016/j.jchromb.2015.01.039\">10.1016/j.jchromb.2015.01.039</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25746576/\">https://pubmed.ncbi.nlm.nih.gov/25746576</a></p></li><li><p>Prakash Kamath, P, et al., &amp; Rathnanand, M (2024). Formulation and evaluation of ibrutinib-loaded glycyrrhizic acid conjugated ovalbumin nanoparticles and ibrutinib-glycyrrhizic acid complex for improved oral bioavailability. <i>Pharmaceutical development and technology</i> 29(10) 1185–1198. DOI:<a href=\"https://doi.org/10.1080/10837450.2024.2436190\">10.1080/10837450.2024.2436190</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39642037/\">https://pubmed.ncbi.nlm.nih.gov/39642037</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end GlycyrrhizicAcid;
